Clinical Trial Update: A Pharmacokinetic Study of a Single-Dose of Diazepam Nasal Spray in Adult Epileptic Patients Experiencing a Seizure Episode [Phase 2]

View source ↗

Summary

This Phase 2 pharmacokinetic study assessed a single-dose diazepam nasal spray in adults with epilepsy during seizure events.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy

Drugs mentioned

• Diazepam nasal spray (diazepam)

Snippet

Sponsor: Acorda Therapeutics | Conditions: Epilepsy | Phase 2 | Status: COMPLETED | Results posted: 2017-03-29